Xstrahl 150 was used to treat Bowen's disease with a forehead lesion with no additional loss of hair or negative cosmetic impact.
Resources
Contact Us
Xstrahl 150 was used to treat Bowen's disease with a forehead lesion with no additional loss of hair or negative cosmetic impact.
Xstrahl 150 was successfully used to treat lentigo maligna with normal visual acuity post treatment and improved cosmesis.
In this case study, Xstrahl 150 was used to treat two patients with Cutaneous Squamous Cell Carcinoma.
Microbeam radiation is typically only available at large synchrotron facilities. SARRP brings this research into a regular laboratory, enabling researchers to study open physics and biology questions in this emerging field. See the results of this study, Evaluation of...
Nasal function and cosmesis are important considerations in the quality of life for nasal ala skin cancer patients. Surgery involves tissue loss, which is likely to lead to impaired function and undesired cosmetic results. Superficial radiotherapy can be an effective...
In this study, Minibeam Radiation Therapy at a Conventional Irradiator: Dose-Calculation Engine and First Tumor-Bearing Animals Irradiation, SARRP was modified to be adjustable for MBRT experiments. Researchers had the chance to conduct systematic and comprehensive...
[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting...
[:us]SARRP was vital in the study, Contrast Enhanced CBCT-Based Fractionated Radiotherapy and Followup Monitor of Orthotopic GBM: a Proof of Concept Study. Significant control of tumor growth and prolongation of mouse survival are clear indicators on the efficacy of...
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, has performed more than 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |